المؤلفون: Britt T.J. van Hagen, Nick P. van Goethem, Ellis Nelissen, Dean Paes, Karin Koymans, Scott van Hoof, Rudy Schreiber, Mark Varney, Adrian Newman-Tancredi, Jos Prickaerts

المساهمون: RS: MHeNs - R3 - Neuroscience, Psychiatrie & Neuropsychologie, Basic Neuroscience 2, Section Psychopharmacology, RS: FPN NPPP II, Cellular and Computational Neuroscience (SILS, FNWI)

المصدر: Molecular and Cellular Neuroscience, 120:103719. Elsevier Science
Molecular and cellular neuroscience, 120:103719. Academic Press Inc.
Molecular and cellular neuroscience 120, 103719 (2022). doi:10.1016/j.mcn.2022.103719

مصطلحات موضوعية: Male, HIGH-EFFICACY, drug effects [Hippocampus], physiology [Recognition, Psychology], NLX-101, hippocampus, Neurogenesis, physiology [Hippocampus], pharmacology [Piperidines], pharmacology [Aminopyridines], HIPPOCAMPAL NEUROGENESIS, DESENSITIZATION, pharmacology [Pyrimidines], Cellular and Molecular Neuroscience, drug effects [Neuronal Plasticity], SCHIZOPHRENIA, Animals, physiology [Neuronal Plasticity], ddc:610, Rats, Wistar, Molecular Biology, therapeutic use [Serotonin 5-HT1 Receptor Agonists], F15599, RECOGNITION, SEROTONIN, PROLIFERATION, physiology [Pattern Recognition, Physiological], drug effects [Pattern Recognition, Physiological], Cell Biology, DEPRESSION, F13714, Rats, pharmacology [Serotonin 5-HT1 Receptor Agonists], DENTATE GYRUS, physiology [Autoreceptors], Pattern separation, physiology [Receptor, Serotonin, 5-HT1A], 5-HT1A, drug effects [Recognition, Psychology]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02b78c02d55a363b652798063571d520Test
https://doi.org/10.1016/j.mcn.2022.103719Test

المؤلفون: André Rex, Vincent Prinz, Hans M.G. Princen, Paul Fischer, Matthias Endres, Frieder Schlunk, Dieter Lütjohann, Ulrich Laufs, Marco Foddis

المصدر: Behavioural brain research 396, 112875-(2021). doi:10.1016/j.bbr.2020.112875
Behavioral Brain Research, 396

مصطلحات موضوعية: Apolipoprotein E, Morris water navigation task, Biomedical Innovation, Open field, Behavioral Neuroscience, chemistry.chemical_compound, Mice, 0302 clinical medicine, Life, drug effects [Behavior, Animal], 0303 health sciences, Behavior, Animal, biology, PCSK9 Inhibitors, Cholesterol, Kexin, lipids (amino acids, peptides, and proteins), Proprotein Convertase 9, Antibody, MHR - Metabolic Health Research, pharmacology [Protease Inhibitors], drug effects [Recognition, Psychology], Healthy Living, Locomotion, medicine.medical_specialty, Side effect, Spatial Learning, Antibodies, 03 medical and health sciences, drug effects [Locomotion], Internal medicine, medicine, Animals, Protease Inhibitors, Behaviour, ddc:610, immunology [Proprotein Convertase 9], PCSK9-inhibitors, 030304 developmental biology, business.industry, PCSK9, drug effects [Spatial Learning], Cognitition, Recognition, Psychology, Animal research, Endocrinology, chemistry, biology.protein, ELSS - Earth, Life and Social Sciences, business, 030217 neurology & neurosurgery

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c57f54470c79c01128abda419148f08aTest

المؤلفون: Sergey Ryazanov, Song Shi, Hans A. Kretzschmar, Wolfgang Zinth, Andrei Leonov, Martin Fuhrmann, Carolin Miklitz, Armin Giese, Daniel Weckbecker, Dan Ehninger, Bettina Göricke, Anne Reiner, Julia Steffen, Jens Wagner, Jochen H. Weishaupt, Alexander Kleinknecht, Johannes Levin, Stefan Remy, Christian Griesinger, Sybille Krauss

المصدر: Acta Neuropathologica
Acta neuropathologica 130(5), 619-631 (2015). doi:10.1007/s00401-015-1483-3

مصطلحات موضوعية: pathology [Tauopathies], 3-(1,3-benzodioxol-5-yl)-5-(3-bromophenyl)-1H-pyrazole, Male, drug effects [Hippocampus], Hippocampus, Protein aggregation, physiology [Cell Death], Frontotemporal dementia and parkinsonism linked to chromosome 17, Synapse, Random Allocation, Tau aggregation inhibitor, pathology [Neurons], drug therapy [Tauopathies], Gliosis, Neurons, Cell Death, Neurodegeneration, pathology [Gliosis], physiology [Neurons], Tauopathy, physiology [Motor Activity], Neuroprotective Agents, Tauopathies, Disease Progression, Female, medicine.symptom, drug effects [Recognition, Psychology], Alzheimer’s disease, Mapt protein, mouse, Genetically modified mouse, physiology [Recognition, Psychology], Clinical Neurology, pharmacology [Benzodioxoles], MAPT protein, human, Mice, Transgenic, tau Proteins, Biology, Motor Activity, Pathology and Forensic Medicine, Cellular and Molecular Neuroscience, Protein Aggregates, mental disorders, medicine, drug effects [Neurons], Animals, ddc:610, Benzodioxoles, Original Paper, pharmacology [Neuroprotective Agents], drug effects [Motor Activity], Anle138b, drug effects [Protein Aggregates], drug effects [Cell Death], Recognition, Psychology, medicine.disease, physiopathology [Gliosis], metabolism [tau Proteins], genetics [tau Proteins], Disease Models, Animal, pathology [Hippocampus], drug therapy [Gliosis], physiopathology [Hippocampus], Pyrazoles, Neurology (clinical), Tau, pharmacology [Pyrazoles], Neuroscience

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d7327b3d660fae3c7d3a6ab97d5440Test
http://europepmc.org/articles/PMC4612332Test

المؤلفون: Daniela A. Bota, Tami John, Naomi Lomeli

المصدر: John, T; Lomeli, N; & Bota, DA. (2017). Systemic cisplatin exposure during infancy and adolescence causes impaired cognitive function in adulthood. BEHAVIOURAL BRAIN RESEARCH, 319, 200-206. doi: 10.1016/j.bbr.2016.11.013. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/2679s83kTest
John, Tami; Lomeli, Naomi; & Bota, Daniela A. (2017). Systemic cisplatin exposure during infancy and adolescence causes impaired cognitive function in adulthood.. Behavioural brain research, 319, 200-206. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/05x725jsTest

مصطلحات موضوعية: Oncology, Male, Aging, drug effects [Recognition (Psychology)], medicine.medical_treatment, Medical and Health Sciences, Developmental psychology, chemically induced [Cognition Disorders], Rats, Sprague-Dawley, Behavioral Neuroscience, 0302 clinical medicine, Discrimination, Psychological, Chemotherapy-related cognitive impairment (CRCI), Discrimination, Conditioning, Psychological, Medicine and Health Sciences, Psychology, 2.1 Biological and endogenous factors, Fear conditioning, Aetiology, Cancer, Pediatric, Age Factors, Cognition, Hematology, Fear, drug effects [Aging], Cognitive test, Mental Health, medicine.anatomical_structure, 030220 oncology & carcinogenesis, medicine.drug, Cisplatin (CDDP), drug effects [Fear], Pediatric Research Initiative, medicine.medical_specialty, Childhood leukemia, Pediatric Cancer, Childhood Leukemia, Antineoplastic Agents, Basic Behavioral and Social Science, Amygdala, Article, toxicity [Antineoplastic Agents], drug effects [Discrimination (Psychology)], 03 medical and health sciences, Rare Diseases, Memory, Internal medicine, Behavioral and Social Science, Acquired Cognitive Impairment, medicine, Animals, Cisplatin, Chemotherapy, Neurology & Neurosurgery, Chemotherapy-related cognitive impairment, Psychology and Cognitive Sciences, Neurosciences, Neurotoxicity, Recognition, Psychology, Stem Cell Research, medicine.disease, toxicity [Cisplatin], Brain Disorders, Rats, Recognition, drug effects [Conditioning (Psychology)], Psychological, Sprague-Dawley, Cognition Disorders, 030217 neurology & neurosurgery, Conditioning

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6ac5c5256ccb87323042465a60b7193Test
http://www.escholarship.org/uc/item/2679s83kTest

المؤلفون: Tatenhorst, Lars, Eckermann, Katrin, Outeiro, Tiago F, Zweckstetter, Markus, Lingor, Paul, Dambeck, Vivian, Fonseca-Ornelas, Luis, Walle, Hagen, Lopes da Fonseca, Tomás, Koch, Jan C, Becker, Stefan, Tönges, Lars, Bähr, Mathias

المصدر: Acta Neuropathologica Communications
Acta Neuropathologica Communications 4(1), 39 (2016). doi:10.1186/s40478-016-0310-y

مصطلحات موضوعية: pharmacology [Protein Kinase Inhibitors], Time Factors, Pyridines, pharmacology [Enzyme Inhibitors], drug effects [Gene Expression Regulation], genetics [Gene Expression Regulation], Mice, pathology [Brain], genetics [Parkinson Disease], A53T mouse model, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Fasudil, metabolism [alpha-Synuclein], Enzyme Inhibitors, therapeutic use [Pyridines], Brain, Parkinson Disease, therapeutic use [Enzyme Inhibitors], genetics [alpha-Synuclein], alpha-Synuclein, drug effects [Brain], SNCAIP protein, human, drug effects [Psychomotor Performance], drug effects [Recognition, Psychology], fasudil, Tyrosine 3-Monooxygenase, metabolism [Parkinson Disease], genetics [Mutation], Mice, Transgenic, Nerve Tissue Proteins, Protein Aggregates, Y 27632, Cell Line, Tumor, therapeutic use [Protein Kinase Inhibitors], Animals, Humans, analogs & derivatives [1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine], ddc:610, pharmacology [1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine], Protein Kinase Inhibitors, metabolism [Nerve Tissue Proteins], Research, drug effects [Protein Aggregates], Recognition, Psychology, pharmacology [Pyridines], Amides, drug therapy [Parkinson Disease], metabolism [Tyrosine 3-Monooxygenase], α-synuclein aggregation, Disease Models, Animal, Gene Expression Regulation, metabolism [Brain], therapeutic use [Amides], Mutation, Parkinson’s disease, pharmacology [Amides], therapeutic use [1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine], genetics [Protein Aggregates], Carrier Proteins, Psychomotor Performance, metabolism [Carrier Proteins]

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::e25ac157886f125890f1f46489256178Test
https://pubmed.ncbi.nlm.nih.gov/27101974Test